AI assistant
Sending…
LIFECORE BIOMEDICAL, INC. \DE\ — Director's Dealing 2021
Jul 28, 2021
33431_dirs_2021-07-28_1fcc6a34-94ed-4b58-8e28-2868fb354612.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LANDEC CORP \CA\ (LNDC)
CIK: 0001005286
Period of Report: 2021-07-27
Reporting Person: Bolles Albert D. (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-07-27 | Incentive Stock Option (right to buy) | $12.14 | A | 8237 | Acquired | 2028-07-27 | Common Stock (8237) | Direct |
| 2021-07-27 | Non-Qualified Stock Option (right to buy) | $12.14 | A | 91763 | Acquired | 2028-07-27 | Common Stock (91763) | Direct |
More from LIFECORE BIOMEDICAL, INC. \DE\
Regulatory Filings
2026
Jun 5
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Director's Dealing
2026
Mar 3
Board/Management Information
2026
Jan 16
Investor Presentation
2025
Nov 17
Interim / Quarterly Report
2025
Nov 6
Earnings Release
2025
Nov 6
Declaration of Voting Results & Voting Rights Announcements
2025
Oct 31
Major Shareholding Notification
2025
Oct 17